$CNBX News Article - Cannabics Pharmaceutical's Interim in-vivo Study Results Show a 27% Lower Tumor Volume in Mice Treated with Company's Proprietary Drug Candidate for Colorectal Cancer https://marketwirenews.com/news-releases/cann...93910.html
(0)
(0)
CNBX Pharmaceuticals Inc (CNBX) Stock Research Links